A Study of GIC-102 (Allogeneic Natural Killer Cells) in Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, and Multiple Myeloma
Conditions: Advanced Solid Tumors; Relapsed/Refractory Non-Hodgkin Lymphoma; Relapsed/Refractory Multiple Myeloma Intervention: Biological: GIC-102 (Allogeneic NK cells) Sponsor: GI Cell, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials